These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18272699)

  • 1. Pharmaceutical expenditures as a correlate of population health in industrialized nations.
    Liu L; Cline RR; Schondelmeyer SW; Schommer JC
    Ann Pharmacother; 2008 Mar; 42(3):368-74. PubMed ID: 18272699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of population ageing on future Danish drug expenditure.
    Kildemoes HW; Christiansen T; Gyrd-Hansen D; Kristiansen IS; Andersen M
    Health Policy; 2006 Feb; 75(3):298-311. PubMed ID: 16399170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to death and health expenditure: an improved model for the impact of demographic change on health care costs.
    Seshamani M; Gray A
    Age Ageing; 2004 Nov; 33(6):556-61. PubMed ID: 15308460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANALYSIS OF TRENDS IN LIFE EXPECTANCIES AND PER CAPITA GROSS DOMESTIC PRODUCT AS WELL AS PHARMACEUTICAL AND NON-PHARMACEUTICAL HEALTHCARE EXPENDITURES.
    Hermanowski T; Bystrov V; Staszewska-Bystrova A; Szafraniec-Buryło SI; Rabczenko D; Kolasa K; Orlewska E
    Acta Pol Pharm; 2015; 72(5):1045-50. PubMed ID: 26665412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life expectancy and health care expenditures: a new calculation for Germany using the costs of dying.
    Breyer F; Felder S
    Health Policy; 2006 Jan; 75(2):178-86. PubMed ID: 15893848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling healthcare expenditures: overview of the literature and evidence from a panel time-series model.
    van Elk R; Mot E; Franses PH
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):25-35. PubMed ID: 20121562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription drugs and the changing concentration of health care expenditures.
    Zuvekas SH; Cohen JW
    Health Aff (Millwood); 2007; 26(1):249-57. PubMed ID: 17211035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health, life expectancy, and health care spending among the elderly.
    Lubitz J; Cai L; Kramarow E; Lentzner H
    N Engl J Med; 2003 Sep; 349(11):1048-55. PubMed ID: 12968089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare financing: how does Turkey compare?
    Akhmedjonov A; Güç Y; Akinci F
    Hosp Top; 2011; 89(3):59-68. PubMed ID: 21864057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender and health outcomes: the impact of healthcare systems and their financing on life expectancies of women and men.
    Asiskovitch S
    Soc Sci Med; 2010 Mar; 70(6):886-95. PubMed ID: 20092922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of newer drugs on health spending: do they really increase the costs?
    Civan A; Köksal B
    Health Econ; 2010 May; 19(5):581-95. PubMed ID: 19404925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional differences in healthy life expectancy in The Netherlands.
    Groenewegen PP; Westert GP; Boshuizen HC
    Public Health; 2003 Nov; 117(6):424-9. PubMed ID: 14522158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do health expenditures 'catch-up'? Evidence from OECD countries.
    Narayan PK
    Health Econ; 2007 Oct; 16(10):993-1008. PubMed ID: 17238220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public and private pharmaceutical spending as determinants of health outcomes in Canada.
    Crémieux PY; Meilleur MC; Ouellette P; Petit P; Zelder M; Potvin K
    Health Econ; 2005 Feb; 14(2):107-16. PubMed ID: 15386658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social Policy Expenditures and Life Expectancy in High-Income Countries.
    Reynolds MM; Avendano M
    Am J Prev Med; 2018 Jan; 54(1):72-79. PubMed ID: 29254555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in life expectancy in Organization for Economic Co-operation and Development countries--1985-2010.
    Zare H; Gaskin DJ; Anderson G
    Scand J Public Health; 2015 Dec; 43(8):786-95. PubMed ID: 26261191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life expectancy in Central and Eastern European countries and newly independent states of the former Soviet Union: changes by gender.
    Reamy J; Oreskovic S
    Croat Med J; 1999 Jun; 40(2):237-43. PubMed ID: 10234067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.